Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Agape ATP Corporation (ATPC:NASDAQ), powered by AI.
Agape ATP Corporation is currently trading at $3.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Agape ATP Corporation on Alpha Lenz.
Agape ATP Corporation's P/E ratio is -5.0.
“Agape ATP Corporation trades at a P/E of -5.0 (undervalued) with modest ROE of -78.4%.”
Agape ATP Corporation is a healthcare-focused enterprise that operates within the multifaceted health and wellness sector. The company's core mission is centered around providing a diverse range of health management solutions. These solutions emphasize preventative healthcare measures, aiming to enhance the overall well-being and quality of life for its clients. Agape ATP Corporation offers these services through a combination of advanced technology, personalized care, and innovative health products. This allows the company to address the needs of individual consumers seeking to maintain optimal health and vitality. By leveraging cutting-edge research and development, Agape ATP Corporation plays a significant role in the healthcare industry, particularly given the rising global demand for health-centric products and services. The company engages in partnerships and collaborative efforts to expand its influence and reach in the market. Through its health management offerings, Agape ATP Corporation contributes to the evolving landscape of global health solutions, ensuring they meet the modern challenges and expectations in personal and public health spheres.
Agape ATP Corporation (ticker: ATPC) is a company listed on NASDAQ in the Consumer Defensive sector (Packaged Foods). It has approximately 16 employees. Market cap is $12M.
The current price is $3.155 with a P/E ratio of -4.97x and P/B of 6.35x.
ROE is -78.40% and operating margin is -194.55%. Annual revenue is $1M.